Targeting ras with protein engineering
A review paper titled "Targeting Ras with protein engineering" has been published in Oncotarget.
Nov 27, 2023
0
0
A review paper titled "Targeting Ras with protein engineering" has been published in Oncotarget.
Nov 27, 2023
0
0
Researchers from The Hospital for Sick Children (SickKids) recently decoded how human antibodies protect us from the malaria parasite, which kills more than 600,000 people worldwide annually. The CMCF facility at the Canadian ...
Nov 27, 2023
0
41
A new paper in Science Advances details how scientists have succeeded in mapping a central part of the immune system—the HLA class II molecules—while accurately predicting how they display fragments of pathogens on the ...
Nov 27, 2023
0
25
To identify potential therapeutic targets and preclinical drug candidates for the treatment of ovarian cancer, researchers led by Tan Li from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences ...
Nov 24, 2023
0
146
People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to research being presented next week at the annual meeting of the Radiological Society ...
Nov 22, 2023
0
0
Thanksgiving is often a time for thinking about your belly. For those with an inflammatory bowel diseases like ulcerative colitis, feasting can be associated with stress, even when food isn't a trigger for the painful symptoms. ...
Nov 21, 2023
0
91
Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of diabetes and weight control drugs like Ozempic, Mounjaro, Trulicity, Victoza, and ...
Nov 21, 2023
0
87
What's a medical drug? Ask someone on the street and they're likely to tell you it's the kind of thing you take when you're unwell.
Nov 20, 2023
0
0
Leukemia is the most common type of cancer in children. Treatment involves intensive chemotherapy, which has severe side effects due to its non-specific mode of action.
Nov 20, 2023
0
64
A pair of studies from the laboratory of Evangelos Kiskinis, Ph.D., associate professor in the Ken and Ruth Davee Department of Neurology's Division of Neuromuscular Disease and of Neuroscience, have uncovered novel cellular ...
Nov 14, 2023
0
37